Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia. [electronic resource]
Producer: 20040826Description: 273-9 p. digitalISSN:- 0021-9150
- Acetamides
- Acetates -- administration & dosage
- Administration, Oral
- Adolescent
- Adult
- Age Factors
- Atorvastatin
- Child
- Cross-Over Studies
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Synergism
- Drug Therapy, Combination
- Enzyme Inhibitors -- administration & dosage
- Female
- Follow-Up Studies
- Heptanoic Acids -- administration & dosage
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Hyperlipoproteinemia Type II -- diagnosis
- Lipoproteins, HDL -- drug effects
- Lipoproteins, LDL -- drug effects
- Male
- Middle Aged
- Multivariate Analysis
- Probability
- Pyrroles -- administration & dosage
- Reference Values
- Risk Assessment
- Severity of Illness Index
- Sex Factors
- Sterol O-Acyltransferase -- antagonists & inhibitors
- Sulfonamides
- Sulfonic Acids -- administration & dosage
- Treatment Outcome
- Sterol O-Acyltransferase 2
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.